- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-01-0010551

Neokem Labs Private Limited
About Neokem Labs Private Limited
Data last updated:
Neokem Labs Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 July 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24299DL2021PTC384262. Its GSTIN is 07AAHCN7223L1Z6 (Delhi).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Arun Kumar and Sanjay Bansal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 14/18 G/F Patel Nagar Road East Patel Nagar, Delhi, India – 110008.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.34 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹52.73 Lakh (net margin -39.5%) and EBITDA of -₹50.72 Lakh (EBITDA margin -38%).
The company has about 29 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹24 Lakh on record.
Neokem Labs Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-01-0010551).
Company details
Recognitions & Rankings of Neokem Labs
Contact details
Neokem Labs Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address14/18 G/F Patel Nagar Road East Patel Nagar, Delhi, India – 110008
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Neokem Labs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Neokem Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Neokem Labs Private Limited, buy the company report.
Financials of Neokem Labs Private Limited
FY 2025 filings availableNeokem Labs Private Limited reported revenue of ₹1.34 Cr (up 475% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue rose 475% in the latest year. EBITDA fell 718% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ₹1.34 Cr | |
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹50.72 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹52.73 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -38% | |
| Net Profit Margin | -39.5% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Neokem Labs Private Limited, buy the company report.
Board of directors of Neokem Labs Private Limited
Neokem Labs has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arun Kumar | Director | 27 Jul 2021 | 5 Years 3 Months | Current |
| Sanjay Bansal Also directs: Neo Facility Management Private Limited | Director | 27 Jul 2021 | 5 Years 3 Months | Current |
| Seema Sharma Also directs: Wisdom Pharma Private Limited, Alight Foods Private Limited, Ideal Infrapromoters Private Limited and 5 more | Director | 27 Jul 2021 | 5 Years 3 Months | Current |
| Rakesh Sharma Also directs: Shivam Agneyastra Private Limited, Wisdom Pharma Private Limited, Alight Foods Private Limited and 5 more | Director | 27 Jul 2021 | 5 Years 3 Months | Current |
Peer comparison
Neokem Labs Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Symlek Healthcare Private Limited | ₹1.34 Cr (FY 2024) | 169.0% | Mohali, Punjab, India | |||
| Mitasa Chemicals Pvt Ltd | ₹1.34 Cr (FY 2025) | 7.0% | Siliguri, West Bengal, India | |||
| Medigrand Pharmaceuticals Private Limited | ₹1.34 Cr (FY 2022) | 43.0% | Harur, Tamil Nadu, India | |||
| Anabolic Remedies Private Limited | ₹1.34 Cr (FY 2025) | -7.0% | Chandigarh, India | |||
| Nature Pure Supercritical Extracts Private Limited | ₹1.34 Cr (FY 2024) | -56.0% | Mumbai, Maharashtra, India | |||
| Neokem Labs Private Limitedthis company | ₹1.34 Cr (FY 2023) | -₹52.73 Lakh | -39.5% | 475.0% | 29 | Delhi, India |
| Medox Biotech India Private Limited | ₹1.33 Cr (FY 2024) | -22.0% | Chennai, Tamil Nadu, India | |||
| Adi Diagnostics Private Limited | ₹1.33 Cr (FY 2025) | 1.0% | Lakdikapool, Hyderabd-4, Telangana, India | |||
| Sesola Facility Services and Security Agency Private Limited | ₹1.33 Cr (FY 2025) | -76.0% | Hyderabad, Telangana, India | |||
| Mimulus Laboratories Private Limited | ₹1.33 Cr (FY 2025) | 1223.0% | Puducherry, India | |||
| Quantum Naturals India Private Limited | ₹1.33 Cr (FY 2023) | 115.0% | Gurugram, Haryana, India |
To see the full peer comparison of Neokem Labs Private Limited, buy the company report.
Auditor
Neokem Labs Private Limited is audited by CHANDER PARKASH & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| CHANDER PARKASH & CO. | FY 2023 | 010770N |
Shareholding
The shareholding of Neokem Labs Private Limited is on record for FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Neokem Labs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Mar 2023 | 100691593 | Others | ₹24 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Neokem Labs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Neokem Labs Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2023, listing 14 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier |
To see the full MSME payment records of Neokem Labs Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Neokem Labs Private Limited has a workforce of 29 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
GST
Neokem Labs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAHCN7223L1Z6 | Delhi | Active | 25 Aug 2021 |
To see the full GST registrations and return filing status of Neokem Labs Private Limited, buy the company report.
Recent activity
Neokem Labs Private Limited has 4 board changes on record since 2021: 4 appointments. The latest: Arun Kumar was appointed as Director on 27 Jul 2021.
Frequently asked questions
Neokem Labs is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 July 2021 (5+ years old) and is registered under CIN U24299DL2021PTC384262.
Neokem Labs has 4 current directors:
- Arun Kumar - Director
- Sanjay Bansal - Director
- Seema Sharma - Director
- Rakesh Sharma - Director
The latest financial statements of Neokem Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Neokem Labs is 07AAHCN7223L1Z6, registered in Delhi.
The CIN (Corporate Identification Number) of Neokem Labs is U24299DL2021PTC384262. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neokem Labs was incorporated on 27 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Neokem Labs by revenue are Symlek Healthcare Private Limited, Mitasa Chemicals Pvt Ltd, Medigrand Pharmaceuticals Private Limited, Anabolic Remedies Private Limited, Nature Pure Supercritical Extracts Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Arun Kumar was appointed as Director on 27 Jul 2021. Rakesh Sharma was appointed as Director on 27 Jul 2021. Sanjay Bansal was appointed as Director on 27 Jul 2021. Neokem Labs has 4 board changes on record in total.
Yes, Neokem Labs is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-01-0010551).
Neokem Labs has 2 MSME Form 1 returns on record for the period ending Mar 2023, listing 14 overdue payments to 1 micro and small supplier. The latest return was filed on 30 Aug 2023.
The registered office of Neokem Labs is at 1418 GF Patel Nagar Road East Patel Nagar, Delhi, India – 110008.
Neokem Labs operates in the pharma industry, in the drug formulation and development segment.

